{"id":"https://openalex.org/W1978461773","doi":"https://doi.org/10.1089/jir.1997.17.31","title":"Intranasal Administration of IFN-\u03b1/\u03b2 Inhibits the Development of Visceral Tumor Metastases","display_name":"Intranasal Administration of IFN-\u03b1/\u03b2 Inhibits the Development of Visceral Tumor Metastases","publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W1978461773","doi":"https://doi.org/10.1089/jir.1997.17.31","mag":"1978461773","pmid":"https://pubmed.ncbi.nlm.nih.gov/9041469"},"language":"en","primary_location":{"id":"doi:10.1089/jir.1997.17.31","doi":"https://doi.org/10.1089/jir.1997.17.31","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.1997.17.31","pdf_url":null,"source":{"id":"https://openalex.org/S109620152","display_name":"Journal of Interferon & Cytokine Research","issn_l":"1079-9907","issn":["1079-9907","1557-7465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon & Cytokine Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112290838","display_name":"Thomas J. Kaido","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"THOMAS J. KAIDO","raw_affiliation_strings":["UPR 274, Groupe de Laboratoires de l'Institut de Recherches Scientifiques sur le Cancer, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPR 274, Groupe de Laboratoires de l'Institut de Recherches Scientifiques sur le Cancer, Villejuif, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5112290838"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3088,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.7968343,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"17","issue":"1","first_page":"31","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.026399999856948853,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intranasal-administration","display_name":"intranasal administration","score":0.8539999723434448},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.8939999938011169},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.753000020980835},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.859000027179718},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.35899999737739563},{"id":"https://openalex.org/keywords/interferon-resistance","display_name":"interferon resistance","score":0.6620000004768372},{"id":"https://openalex.org/keywords/interferon-antibodies","display_name":"interferon antibodies","score":0.45899999141693115},{"id":"https://openalex.org/keywords/h-2-complex","display_name":"H-2 complex","score":0.4740000069141388},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.3440000116825104}],"concepts":[{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.7883741855621338},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6850050687789917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6319213509559631},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.6040860414505005},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5557476878166199},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5394303202629089},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.499345064163208},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43553948402404785},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.432498037815094},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.425870805978775},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3426355719566345},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.31704702973365784}],"mesh":[{"descriptor_ui":"D000281","descriptor_name":"Administration, Intranasal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007942","descriptor_name":"Leukemia, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008811","descriptor_name":"Mice, Inbred DBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014781","descriptor_name":"Viscera","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/jir.1997.17.31","doi":"https://doi.org/10.1089/jir.1997.17.31","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.1997.17.31","pdf_url":null,"source":{"id":"https://openalex.org/S109620152","display_name":"Journal of Interferon & Cytokine Research","issn_l":"1079-9907","issn":["1079-9907","1557-7465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon & Cytokine Research","raw_type":"journal-article"},{"id":"pmid:9041469","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9041469","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1978375745","https://openalex.org/W1995391655","https://openalex.org/W2008299447","https://openalex.org/W2013362829","https://openalex.org/W2015157357","https://openalex.org/W2023353270","https://openalex.org/W2029860680","https://openalex.org/W2040774216","https://openalex.org/W2043071269","https://openalex.org/W2050185154","https://openalex.org/W2065036147","https://openalex.org/W2072701951","https://openalex.org/W2078106035","https://openalex.org/W2090077307","https://openalex.org/W2091173330","https://openalex.org/W2103149709","https://openalex.org/W2140431211","https://openalex.org/W2147818004","https://openalex.org/W2314825638","https://openalex.org/W2327730411","https://openalex.org/W2330910817","https://openalex.org/W4298332200"],"related_works":["https://openalex.org/W2171765809","https://openalex.org/W1964288721","https://openalex.org/W2009132260","https://openalex.org/W2086504551","https://openalex.org/W1985993654","https://openalex.org/W2078106035","https://openalex.org/W2421962856","https://openalex.org/W2088233396","https://openalex.org/W1989278523","https://openalex.org/W2115820607"],"abstract_inverted_index":{"Intranasal":[0],"administration":[1],"of":[2,5,13,73,93,103,120,140],"10(4)":[3,79,104],"U":[4,80,105],"murine":[6],"interferon":[7],"(IFN)-alpha/beta":[8],"prolonged":[9,89],"the":[10,70,86,90,108,124,137],"survival":[11,71,91,138],"time":[12,72,92,139],"DBA/2":[14,51,76,94,151,165],"mice":[15,52,95,142,152,167],"injected":[16],"i.v.":[17,144,154,169],"with":[18,35,54,96,145,155,170],"10(5)":[19],"(>":[20],"20,000":[21],"LD50)":[22],"IFN-alpha/beta-resistant":[23],"3C18":[24,36,49,74,99],"Friend":[25],"leukemia":[26],"cells":[27,173],"(FLC).":[28],"Long-term":[29],"survivors":[30],"rejected":[31],"a":[32,83],"second":[33],"challenge":[34],"FLC":[37,100],"without":[38],"additional":[39],"IFN-alpha/beta":[40,42,81,106,121,134],"treatment.":[41],"administered":[43,133],"intranasally":[44],"was":[45,110],"not":[46],"effective":[47,112,115],"in":[48,180],"FLC-challenged":[50,75],"pretreated":[53],"antibody":[55],"to":[56],"IFN-alpha/beta.":[57],"Recombinant":[58],"human":[59],"IFN-alpha":[60],"BDBB,":[61],"which":[62],"is":[63],"cross-reactive":[64],"on":[65],"mouse":[66],"cells,":[67,150,160],"also":[68,88,135],"increased":[69,136],"mice.":[77],"Placing":[78],"twice":[82],"day":[84],"into":[85,107],"nostrils":[87],"3-day":[97],"established":[98],"tumors.":[101],"Administration":[102],"nasopharynx":[109],"equally":[111],"or":[113,126,129],"more":[114],"than":[116],"an":[117],"equivalent":[118],"amount":[119],"given":[122],"by":[123,130],"i.p":[125],"oral":[127],"routes":[128],"gavage.":[131],"Intranasally":[132],"C57B1/6":[141,162],"challenged":[143,153,168],"EL4":[146],"T":[147],"cell":[148,158],"lymphoma":[149,159],"L1210R":[156],"B":[157],"and":[161,164],"(H-2b)":[163],"(H-2d)":[166],"B16":[171],"melanoma":[172],"(H-2b).":[174],"These":[175],"results":[176],"may":[177],"be":[178],"important":[179],"devising":[181],"novel":[182],"therapeutic":[183],"strategies":[184],"for":[185],"malignant":[186],"disease":[187],"using":[188],"type":[189],"I":[190],"IFN.":[191]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}